Sign in
8-K

Current Report

Cocrystal Pharma, Inc. Filed Acc 0001493152-20-003917

Material agreement · Agreement ended · Executive or director change · Regulation FD disclosure · Other events

  • Item 1.01 Entry into a material definitive agreement
  • Item 1.02 Termination of a material definitive agreement
  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading form8k.htm…